by Shernan Holtan, MD
This spotlight features Shernan Holtan, MD, chief of blood and marrow transplantation at Roswell Park. A leader in regenerative therapies and GVHD research, she shares the early experiences that...
by Sita Bhella, MD, MEd, FRCPC
Immune effector cell-associated neurotoxicity syndrome is a complication of chimeric antigen receptor T-cell therapy. The condition is characterized by neurologic symptoms, such as tremors,...
by Filippo Milano
This spotlight features Filippo Milano, MD, PhD, a physician-scientist at Fred Hutch and ASTCT board member. As the inaugural Endowed Chair in Cord Blood Research, he shares his journey from Rome...
by ASTCT Talks
In this episode of ASTCT Talks, Dr. Corey Cutler sits down with Dr. Ana Barata to discuss the critical role of physician-patient communication in GVHD and stem cell transplantation.
by ASTCT Talks
In this episode of ASTCT Talks, Dr. Rahul Banerjee sits down with Dr. Kenneth Lim and Dr. Yi Lin of Mayo Clinic to discuss a critical and emerging topic in CAR T-cell therapy: delayed...
by David Porter, MD
In this month’s President’s Message, Dr. David Porter highlights the 30th anniversary of ASTCT’s official journal, Transplantation and Cellular Therapy, celebrating its...